Clinic
Millinocket Regional Hospital
Millinocket Regional Hospital was paid $1.41M by Medicaid between Jan 2018 and Dec 2024, across 133 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.
33Billing provider infoMILLINOCKET REGIONAL HOSPITAL
MILLINOCKET, ME 04462
MILLINOCKET, ME 04462
33aNPI1275646150assigned 08/16/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.41M
24GClaims175,447
24DCodes billed133
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Maine
Rank by total paid#2 of 28
Median peer was paid$297K
This provider vs. median4.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,076 | $162K | |
| 2019 | 23,053 | $206K | |
| 2020 | 21,013 | $190K | |
| 2021 | 24,487 | $187K | |
| 2022 | 29,673 | $235K | |
| 2023 | 29,772 | $248K | |
| 2024incomplete | 25,373 | $178K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 11,162 | 7,761 | $244K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 8,140 | 6,102 | $233K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 2,854 | 2,497 | $187K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.7% | 17,442 | 10,545 | $137K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.6% | 1,069 | 1,008 | $134K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.0% | 1,177 | 1,093 | $71K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.0% | 2,990 | 2,355 | $42K |
| 71046 | Radiologic examination, chest; 2 views | 2.4% | 2,777 | 2,593 | $34K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.3% | 3,905 | 3,379 | $32K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 3,785 | 1,424 | $31K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.5% | 1,020 | 641 | $22K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.4% | 2,031 | 1,894 | $20K |
121 more codes
| 80053 | Comprehensive metabolic panel | 1.3% | 12,346 | $19K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.2% | 2,410 | $17K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 2,334 | $17K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 2,529 | $15K |
| 71045 | Radiologic examination, chest; single view | <1% | 810 | $9K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 100 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,900 | $9K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,657 | $9K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,810 | $9K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 76 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,932 | $8K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 69 | $6K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 376 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 469 | $5K |
| 71250 | <1% | 83 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,011 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,418 | $4K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 27 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,407 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,265 | $3K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 201 | $2K |
| 84484 | <1% | 3,586 | $2K | |
| G0378 | Hospital observation service, per hour | <1% | 21 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 403 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 442 | $2K |
| 96376 | <1% | 330 | $2K | |
| 73564 | <1% | 100 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 83 | $2K |
| 83735 | <1% | 3,836 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 46 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 196 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 154 | $1K |
| 94761 | <1% | 410 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,621 | $1K |
| 85610 | <1% | 1,920 | $1K | |
| 93041 | <1% | 1,304 | $1K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 14 | $981.62 |
| 97035 | <1% | 175 | $976.48 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,999 | $949.58 |
| 81001 | <1% | 2,476 | $884.71 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 88 | $866.38 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 349 | $842.78 |
| 82728 | <1% | 581 | $836.92 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 440 | $823.94 |
| 73030 | <1% | 38 | $795.86 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,680 | $716.82 |
| 83690 | <1% | 1,848 | $685.13 | |
| 80306 | <1% | 998 | $678.76 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 71 | $652.03 |
| 80061 | Lipid panel | <1% | 2,648 | $634.53 |
| 20610 | <1% | 43 | $611.40 | |
| A9270 | Non-covered item or service | <1% | 1,557 | $591.59 |
| 99070 | <1% | 29 | $581.46 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 660 | $572.94 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,073 | $562.61 |
| 87186 | <1% | 694 | $548.51 | |
| 83540 | <1% | 728 | $548.02 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 328 | $539.38 |
| 83550 | <1% | 345 | $482.89 | |
| 96367 | <1% | 58 | $421.66 | |
| 87077 | <1% | 879 | $401.50 | |
| 71271 | <1% | 40 | $393.44 | |
| 83605 | <1% | 1,029 | $385.60 | |
| 97161 | <1% | 45 | $372.37 | |
| 72100 | <1% | 13 | $354.96 | |
| 84466 | <1% | 378 | $330.11 | |
| 83880 | <1% | 200 | $324.48 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 145 | $324.39 |
| 85380 | <1% | 362 | $305.58 | |
| 81003 | <1% | 1,978 | $305.35 | |
| 85652 | <1% | 1,037 | $305.21 | |
| 74019 | <1% | 40 | $303.62 | |
| 87040 | <1% | 458 | $294.98 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,353 | $282.87 |
| 73502 | <1% | 14 | $277.64 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 59 | $269.14 |
| 94760 | <1% | 150 | $244.14 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 265 | $232.64 |
| 86140 | <1% | 706 | $220.88 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 99 | $193.49 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 110 | $186.01 |
| J3490 | Unclassified drugs | <1% | 28 | $151.08 |
| 86141 | <1% | 322 | $145.12 | |
| 87631 | <1% | 157 | $139.14 | |
| 93226 | <1% | 12 | $114.15 | |
| 93225 | <1% | 12 | $113.15 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 31 | $103.71 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,160 | $101.81 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $93.65 |
| 87070 | <1% | 386 | $93.09 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 843 | $85.04 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 18 | $81.95 |
| 73630 | <1% | 14 | $81.09 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 46 | $78.70 |
| 73610 | <1% | 16 | $58.54 | |
| 87427 | <1% | 121 | $54.21 | |
| 85730 | <1% | 159 | $42.08 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 17 | $41.93 |
| 82607 | <1% | 112 | $40.62 | |
| 85379 | <1% | 241 | $25.18 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 77 | $23.09 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 29 | $18.95 |
| 82043 | <1% | 24 | $18.09 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 29 | $17.38 |
| 84439 | <1% | 45 | $17.23 | |
| 84703 | <1% | 613 | $13.73 | |
| 84100 | <1% | 13 | $12.22 | |
| 92015 | Determination of refractive state | <1% | 44 | $11.06 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 98 | $9.21 |
| 81015 | <1% | 27 | $5.84 | |
| 82565 | <1% | 12 | $5.78 | |
| 82150 | <1% | 148 | $3.93 | |
| 87205 | <1% | 28 | $3.07 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 13 | $2.03 |
| 96368 | <1% | 12 | $2.01 | |
| Q3014 | Telehealth originating site facility fee | <1% | 14 | $1.91 |
| 87081 | 0% | 15 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 14 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 73 | $0.00 |
| 87420 | 0% | 14 | $0.00 | |
| 87400 | 0% | 83 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETERSON, BOB (CEO)
| Provider | Location | Paid |
|---|---|---|
| Escalon Community Ambulance INC | Escalon, CA | $118K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.